Saturday, February 08, 2014


Rick Perlstein and Amanda Marcotte have done good work exposing movement conservatism as a massive grifting game and this email I received from a Bagger group is a little more evidence:

To view this as a web page, click here
Tea Party News
Dear Tea Party Reader,

Please find below an important message from one of our sponsors, Dr. Al Sears, MD. He has some special information to share with you.

Thank you.


This Hushed-Up Cure for Heart Disease, Diabetes, Alzheimer's and Cancer Has Been Censored, Banned, and Blacklisted... Until Now!

Dear Friend,
This Harvard study should have made front page news around the world.  It’s the kind of news that would have most Americans falling off their sofas... if they ever heard it.
You see, the Harvard researchers behind this study discovered a way to "flip a switch" inside your cells that makes it virtually impossible for any chronic disease to exist in that cell...
...and if you already have diseased cells, you can make them disappear as if they never existed at all.
So would it surprise you if I told you the FDA created laws to block access to this amazing technology? In some cases the laws are so tight, experts are not even allowed to TALK about it. 
This hushed-up, breakthrough technology provides a possible CURE for everything from cancer and heart disease, to diabetes and Alzheimer’s.
And it’s available RIGHT NOW. But it never sees the light of day.
Today, I'm blowing the whistle on the FDA.
Let him show you what I'm talking about.
You and your family have a right to know.
To Your Good Health,
Dr. Al Sears, MD

This email is never sent unsolicited. You have received this email because you subscribed to it or someone forwarded it to you. To opt out, see the links below.

If this email has been forwarded to you and you would like to sign up:

For information on advertising with, please contact:

Remove your email address from our list. We respect your right to privacy. View our policy.

This email was sent by:, 1300 Pennsylvania Avenue #190, Suite 428 Washington, D.C. 20004

No comments: